One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL	B-Cell Non-Hodgkin Lymphoma-Recurrent; B-Cell Non-Hodgkin Lymphoma-Refractory	Recruiting	Not applicable	2025-06-03		NCT06618313

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing GoBroad Hospital	42
Ruijin Hospital	454

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Lymphoma and Myeloma, Yuhengnan Road, Changping District, Beijing	Beijing	China	1

Clinical trials